July 2004

Introduction

The US Food and Drug Administration (FDA) approved labeling changes for the antidepressants Effexor and Effexor XR (venlafaxine), Paxil (paroxetine), Serzone (nefazodone), and Wellbutrin (bupropion hydrochloride).

This month's column reviews FDA new product approvals and labeling changes for:

Anticoagulants

Antidepressants

Anti-infective Agents

Medscape Pharmacists. 2004;5(2) © 2004 Medscape

Cite this: July 2004 - Medscape - Jul 14, 2004.